Estimation of Pulmonary Vascular Resistance: Correlation between Echocardiography and Catheterization Data In Patients With Congenital Heart Disease
- Dr Manojkumar Rohit, Post Graduate Institute of Medical Education & Research - chandigarh India, India
|
Pulmonary Veno-Occlusive Disease in a Child with Prothrombine Gene Mutation
- Dr Birsen Ucar, Professor in Eskisehir Osmangazi University Faculty of Medicine Department of Pediatrics, Section of Cardiology, Turkey
|
Efficacy of Bosentan Treatment in Children with Eisenmenger Syndrome and Primary Pulmonary Hypertension
- Prof Kemal Baysal, Ondokuz Mayis University, Faculty of Medicine, Pediatric Cardiology Department, Turkey
|
Single-Center Experience in Large Cohort of Patients with Pulmonary Arterial Hypertension Related to Congenital Heart Disease over 15 years: Effect of New Therapies
- Sotiria C Apostolopoulou, Onassis Cardiac Surgery Center, Athens, Greece, Greece
|
Impact on clinical parameters using new farmacological therapies in patients with pulmonary arterial hypertension due to congenital heart disease
- Paola Argiento, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
- Michele D'Alto, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
- Emanuele Romeo, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
- Giuliano D'Alterio, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
- Berardo Sarubbi, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
- Giuseppe Santoro, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy, Italy
- Dr Maria Giovanna Russo, Italy
- Raffaele Calabrò, Chair of Cardiology, Second University of Naples, Monaldi Hospital, Naples, Italy
|
Fetal and neonatal ventricular load markers in experimental congenital diaphragmatic hernia
- Dr Maria J Baptista, Pediatric Cardiology, H. S. João, Porto; Life and Health Sciences Research Institute, Minho University, Portugal
|
Cardiac function in pulmonary hypertension: the usefulness of biochemical markers and echo in management of CDH infants
- Dr Maria J Baptista, Pediatric Cardiology, H. S. João, Porto; Life and Health Sciences Research Institute, Minho University, Portugal
|
Prevalence and prognostic value of acute pulmonary vasodilator response in children and adults with pulmonary arterial hypertension
- Rolf MF Berger, Center for Congenital Heart Diseases, Dept of Pediatric Cardiology, University Medical Center Groningen
|
The Impact of Current Therapies on Survival in Children with Idiopathic Pulmonary Arterial Hypertension
- Dr Tara Bharucha, Australia
|
A descriptive analysis of pulmonary arterial hypertension in children from the East of Scotland 1983 to 2008
- Dr Janet E Burns, Royal Hospital for Sick Children, Edinburgh, United Kingdom
|
Inhaled iloprost In Control Of Postoperative Inhaled iloprost In Control Of Postoperative Pulmonary Hypertension After Pediatric Cardiac Surgery:A One Year, Single Center, Open Label Pilot Trial
- Xiaoman Cai, Department of cardiovascular surgery, Shanghai Children’s Medical Center, Medical college of Shanghai Jiaotong University, China
|
Ventricular septal defect closure with double patch technique in paediatric patients with increased pulmonary vascular resistance
- Dr Jorge L Cervantes, “Ignacio Chávez” National Cardiology Institute of México, Mexico
- Dr Pedro J Curi-Curi, “Ignacio Chávez” National Cardiology Institute of México, Mexico
|
Selection of muscular ventricular septal occluders versus duct occluders to close large patent arterial ducts with severe pulmonary arterial hypertension
- Dr Ramyashri Chandrasekaran, MIOT Hospital, Chennai, India, India
|
The Effect of Perioperative inhaled Iloprost Treatment on Congenital Heart Disease with Pulmonary Arterial Hypertension
- Prof Deok Young Choi, Department of Pediatrics, Gil medical Center, Gachon University of Medicine and Science, Korea
|
The role of Rho A/Rho-kinase pathway on the pathogenesis of pulmonary hypertension secondary to left ventricular dysfunction
- Dr Zen-Kong Dai, Dept. of Pediatrics, Kaohsiung Medical University, Taiwan
|
Differential diagnosis of children with hypertension
- Dr Zhong-Dong Du, Beijing Children's Hospital, Capital Medical University, China
|
High altitude pulmonary edema (HAPE)
- Aldo M Gamez Schroeder, Hospital "Dr. Pablo Soria" San Salvador de Jujuy, Jujuy, Argentina, Argentina
|
The effect of living in the high plateau on cardiovascular system
- Aldo M Gamez Schroeder, Hospital "Dr. Pablo Soria" San Salvador de Jujuy, Jujuy, Argentina, Argentina
|
Hypoventilation easily leads to severe pulmonary hypertension in Down syndrome patients with congenital heart disease
- Yuji Hamamichi, OSAKA MEDICAL CENTER AND RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH, Japan
|
Combination therapy of bosentan, beraprost and HOT improve pulmonary artery hypertension related to congenital heart disease in contraindications for right heart bypass surgery
- Keiichi Hirono, Department of Pediatrics, Faculty of Medicine, University of Toyama, Japan
|
Gene Expression of Endothelin-1 and Endothelin Receptor A on Monocrotaline-Induced Pulmonary Hypertension in Rats after Bosentan Treatment
- Young Mi Hong, Department of Pediatrics, School of Medicine, Ewha Womans University Hospital, Korea
|
Gene Expression of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats
- Young Mi Hong, Department of Pediatric, School of Medicine, Ewha Womans Univeristy, Korea
|
Adverse effect of Estrogen on Bone Morphogenetic Protein Receptor signal pathway in pulmonary arterial endothelial cells
- Hiroaki Ichimori, Department of Pediatrics, Osaka university graduated school og medicine, Japan
|
Outcome of surgical repair of patients with left-to-right (LR) shunt lesion and severe pulmonary arterial hypertension (PAH)
- Dr Soo In Jeong, Department of Pediatrics, Samsung Medical Center, SungKyunKwan University School of Medicine, Korea
|
Effect of hydrogen sulfide on the apoptosis of pulmonary artery smooth muscle cell in rats with pulmonary hypertension induced by high pulmonary blood flow
- Dr Hongfang Jin, Department of Pediatrics, Peking University First Hospital,Beijing, China
|
Use of Iloprost in Infant of Bronchopulmonary Dysplasia with Pulmonary Arterial Hypertension
- Dr Nam Su Kim, Dept. of Pediatrics, Hanyang University Hospital, Korea
|
Decline in Arterial pO2 after Exercise can Help Stratify Patients with Large Atrial Septal Defect and Pulmonary Hypertension
- Raman Krishna Kumar, Amrita Institute of Medical Sciences, Kochi, Kerala, India
|
Reversible Course of Pulmonary Arterial Hypertension
- A/Prof Alisa Limsuwan, Division of Pediatric Cardiology,Ramathibodi Hospital, Mahidol University, Thailand
|
Outcome of children with pulmonary arterial hypertension in the era of antiproliferative medication
- Rosa Laura E van Loon, Department of Pediatric Cardiology, University Medical Center Groningen, Groningen, The Netherlands
|
Efficacy of combination of Pulmonary Artery Banding and oral Sildenafil in children with early Eisenmenger VSD : 3 year Follow up
- Viresh Mahajan, Batra Hospital, New Delhi, India
|
Use of ductus arteriosus in management of pulmonary artery hypertension
- Senthil K Subbian, Division of cardio-thoracic surgery, National Heart Centre, Singapore, Singapore
|
Pulmonary and systemic hypertension in the setting of Moya-Moya disease due to disseminated fibromuscular dysplasia
- Takeshi Nakano, Department of Pediatric Cardiology, Ehime central prefectural Hospital, Ehime, Japan, Japan
|
Oral Sildenafil for Persistent Pulmonary Hypertension Early After Congenital Cardiac Surgery
- Dr Shintaro Nemoto, Department of Cardiovascular Surgery, Osaka Medical College Hospital, Japan
|
Pretreatment with phosphodiesterase inhibitors(Sildenafil/Milrinone) prevents pulmonary hypertensive crisis in children undergoing cardiac surgery
- Dr Usha Pratap, Department of Pediatric Cardiology,Deenanath Mangeshkar Hospital,Erandawana,Pune 411004, India
|
Use of bosentan hydrate, an endothelin-1 dual receptor blocker, for treatment of impaired pulmonary circulation after congenital cardiac surgery
- Dr Tomoyasu Sasaki, Department of Cardiovascular Surgery, Osaka Medical College Hospital, Japan
|
Paediatric Pulmonary Arterial Hypertension: Effects of Long-Term Treatment with Bosentan
- Dr Ingram Schulze-Neick, Great Ormond Street Hospital, London, UK, United Kingdom
|
Twenty three years old man who was treated as PPH for 11 years finally revealed as multiple peripheral PS: A case report
- Dr Yasuhiro Tsuji, Division of Pediatrics and Perinatology,Tottori University, Japan
|
Relationship of VEGF/receptors level with hemodynamic parameters in cyanotic congenital heart disease with diminished pulmonary flow
- Sedef Tunaoglu, Gazi University, Medical Faculty, Department of Pediatric Cardiology, Turkey
- Ilknur Aslan, Gazi University, Medical Faculty, Department of Pediatrics, Turkey
|
Severe Pulmonary Hypertension in an Infant Girl with Incontinentia Pigmenti
- Kenji Yasuda, Department of Pediatrics, Shimane University Faculty of Medicine, Japan
|
Intravenous Transplantation of Syngenic Bone Marrow-derived Mononuclear Cells Improves Pulmonary Artery hypertension by Paracrine Effect through VEGF-VEGF Receptor System
- Dr Homare Yoshida, Department of Cardiovascular Surgery, IHBS, The University of Tokushima Graduate school, Japan
|
The changes of pulmonary arterial pressure after tonsillectomy and sdonoidectomy in childhood
- Gyoung-bin Yun, Department of Pediatrics, Chungnam National University Hospital, Korea
|
Beneficial Effect of Oral Bosentan in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
- Limin Zhu, Department of cardiovascular surgery, Shanghai Children’s Medical Center, Medical college of Shanghai Jiaotong University, China
|
Characteristics and Outcomes of Children with Pulmonary Arterial Hypertension Referred to a Single Statewide Service
- Dr Tara Bharucha, Australia
|